Graham Capital Management »

Revance Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 400k 3.04
2024-09-30 $2.2M 426k 5.19
2024-06-30 $1.1M 417k 2.57
2023-09-30 $122k 11k 11.47
2023-06-30 $817k 32k 25.31
2022-03-31 $390k 20k 19.47